Dose-dependent suppression of DNA synthesis in vitro as a predictor of clinical response in adult acute myeloblastic leukemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D003561:Cytarabine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D013936:Thymidine / Q000378:metabolism
D004273:DNA, Neoplasm; D003561:Cytarabine; D004317:Doxorubicin; D013936:Thymidine